Publications by authors named "Joachim Schessl"

Claim this Profile
E
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study.
Rohit Aggarwal, Joachim Schessl, Zsuzsanna Bata-Csörgő, Mazen M Dimachkie, Zoltan Griger

Rheumatol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study.
Christina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, Mazen M Dimachkie, Zoltan Griger

Rheumatology (Oxford)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
Rohit Aggarwal, Joachim Schessl, Christina Charles-Schoeman, Zsuzsanna Bata-Csörgő, Mazen M Dimachkie

Arthritis Res Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM study.
Victoria P Werth, Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, Todd Levine

EClinicalMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusually severe muscular dystrophy upon in-frame deletion of the dystrophin rod domain and lack of compensation by membrane-localized utrophin.
Svetlana Gorokhova, Joachim Schessl, Yaqun Zou, Michele L Yang, Peter T Heydemann

Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl

N Engl J Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Intravenous Immune Globulin in Dermatomyositis.
Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, Mazen M Dimachkie

N Engl J Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020.
Christoph Vollmuth, Olga Miljukov, Mazen Abu-Mugheisib, Anselm Angermaier, Jessica Barlinn, Joachim Schessl

Eur J Neurol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, Mazen M Dimachkie, Irene Beckmann

Medicine (Baltimore)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a Novel ACTA1 Mutation With a Dominant Progressive Scapuloperoneal Myopathy in an Extended Family.
Kristen Zukosky, Katherine Meilleur, Bryan J Traynor, Jahannaz Dastgir, Livija Medne, Joachim Schessl

JAMA Neurol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo characterization of human myofibrillar myopathy genes in zebrafish.
John B Bührdel, Sofia Hirth, Mirjam Kessler, Sören Westphal, Monika Forster, Joachim Schessl

Biochem Biophys Res Commun· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel recessive myotilin mutation causes severe myofibrillar myopathy.
Joachim Schessl, Elisa Bach, Simone Rost, Sarah Feldkirchner, Christiana Kubny

Neurogenetics· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.
Edoardo Malfatti, Montse Olivé, Ana Lía Taratuto, Pascale Richard, Guy Brochier, Joachim Schessl

J Neuropathol Exp Neurol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.
Sarah Feldkirchner, Maggie C Walter, Stefan Müller, Christiana Kubny, Sabine Krause, Joachim Schessl

Neuromuscul Disord· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.
Maggie C Walter, Peter Reilich, Simone Thiele, Joachim Schessl, Herbert Schreiber

Orphanet J Rare Dis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-specific protein aggregates in myofibrillar myopathies: laser microdissection and differential proteomics for identification of plaque components.
Sarah Feldkirchner, Joachim Schessl, Stefan Müller, Benedikt Schoser, Franz-Georg Hanisch

Proteomics· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy.
Joachim Schessl, Wolfram Kress, Benedikt Schoser

Muscle Nerve· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing body myopathy and other FHL1-related muscular disorders.
Joachim Schessl, Sarah Feldkirchner, Christiana Kubny, Benedikt Schoser

Semin Pediatr Neurol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
Janbernd Kirschner, Joachim Schessl, Ulrike Schara, Bernd Reitter, Georg M Stettner

Lancet Neurol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy.
Peter Reilich, Benedikt Schoser, Nicolai Schramm, Sabine Krause, Joachim Schessl

Neuromuscul Disord· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maturation of inhibitory and excitatory motor cortex pathways in children.
Michael Walther, Steffen Berweck, Joachim Schessl, Michaela Linder-Lucht, Urban M Fietzek

Brain Dev· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.
Joachim Schessl, Ana L Taratuto, Caroline Sewry, Roberta Battini, Steven S Chin

Brain· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.
Belinda S Cowling, Meagan J McGrath, Mai-Anh Nguyen, Denny L Cottle, Anthony J Kee, Joachim Schessl

J Cell Biol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of GluR1 in activity-dependent motor system development.
Lei Zhang, Joachim Schessl, Markus Werner, Carsten Bonnemann, Guoxiang Xiong

J Neurosci· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predominant fiber atrophy and fiber type disproportion in early ullrich disease.
Joachim Schessl, Nathalie M Goemans, Alexandra I Magold, Yaqun Zou, Ying Hu

Muscle Nerve· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis